ECG Laboratory
Richmond Pharmacology’s Core ECG Laboratory was established in 2004 to provide centralized electrocardiography data analysis for both Richmond’s in house clinical trials, in addition to analysis for multicenter clinical trials.
Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of experienced cardiologist’s headed by Professor John Camm, a key opinion leader in Thorough QT Trials.
Richmond Pharmacology’s Core ECG Laboratory has worked with numerous clinical units worldwide and participated in 200 clinical trials sponsored by pharmaceutical companies.
Analysis services include rest and exercise ECG analysis, detailed QT analysis, entry criteria validation, and cardiac event classification and holter provision, analysis and review. Drug development range of services cover phase I-IV ECG safety studies for cardiovascular and non-cardiovascular compounds. Rest, exercise and QT digitized ECG analysis are performed using Richmond’s bespoke and integrated MUSE setup.
Additional Core ECG Lab services include:
- Distribution of ECG acquisition units for electronic ECG capture and analysis
- Provide investigator/coordinator certification and/or training
- Prepare study specific manual of operations for ECG related issues
- Monitor ECG quality
- Provide status reports
- Provide technical and clinical expertise
- Statistical support and data analysis